c-Jun NH2-Terminal Kinase Is Crucially Involved in Renal Tubulo-Interstitial Inflammation
Open Access
- 28 August 2009
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 331 (3), 896-905
- https://doi.org/10.1124/jpet.109.154179
Abstract
Chronic inflammation is a major outcome determinant in several renal disorders. Induction of monocyte chemoattractant protein (MCP)-1 expression in tubular epithelial cells contributes importantly to the recruitment of inflammatory cells from the circulation toward the damaged tubulo-interstitium. Because the MCP-1 gene contains several c-Jun binding sites, we hypothesized that the c-Jun NH2-terminal kinase (JNK) pathway regulates MCP-1 expression and subsequently tubulo-interstitial inflammation. This was investigated in cultured rat tubular epithelial cells (NRK-52E) and in the rat unilateral ischemia/reperfusion (I/R) model. In NRK-52E cells, the JNK inhibitor anthra(1,9-cd)pyrazol-6(2H)-one-1,9-pyrazoloanthrone (SP600125) reduced interleukin-1β-, transforming growth factor-β-, or bovine serum albumin-induced MCP-1 expression in a potent manner (up to 150-fold). In the rat I/R model, JNK activation was low in controls but induced in tubular cells from 30 min after I/R. The extent of JNK activation correlated with interstitial macrophage accumulation. Treatment with SP600125 (30 mg/kg/day i.p. for 4 days) reduced renal c-Jun activation; MCP-1, osteopontin, and vimentin expression; and interstitial macrophage and T-cell accumulation (all p < 0.05). In human renal disease, we also found induction of JNK activation, which correlated strongly with interstitial macrophage accumulation, tubulointerstitial fibrosis, and renal function loss. In conclusion, these data indicate that the JNK pathway plays an important role in renal inflammation, at least in part through induction of MCP-1 gene expression in tubular epithelial cells.Keywords
This publication has 39 references indexed in Scilit:
- SP600125, a selective JNK inhibitor, protects ischemic renal injury via suppressing the extrinsic pathways of apoptosisLife Sciences, 2007
- PKB and megalin determine the survival or death of renal proximal tubule cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitisImmunology, 2006
- ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy ratsThe Journal of Pathology, 2006
- Mitogen activated protein kinase signaling in the kidney: target for intervention?Signal Transduction, 2006
- Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertensionGene Therapy, 2005
- JNK mediates hepatic ischemia reperfusion injuryJournal of Hepatology, 2005
- Allergen-induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N-terminal kinaseBritish Journal of Pharmacology, 2003
- Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-κBKidney International, 2002
- Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusionKidney International, 1999